Gilead’s $11.9 billion purchase of Kite Pharma in 2017 didn’t follow the script, with two big write-downs in the value of the asset since then, but a fresh approval for a CAR-T therapy could claw back ...
The FDA has approved Kite Pharma's Tecartus as a treatment for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL), making CAR-T therapy an option for an entirely ...
On December 17, 1903, the Wright brothers flew their "Flyer" four times, with their longest flight lasting 59 seconds and covering 852 feet. To assist in making a turn, the Wrights realized that the ...